Cell and Gene Therapy Catapult
Is this your company? Claim this profile
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Cell and Gene Therapy Catapult is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:United Kingdom
Founded:2011
Employees:2,406
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Europe
International Regulatory
EU GMP Certificates
2
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval 73OY4A
PMDA · #APR-CUTZAQMS · 2019-01-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-7WQFZ0NT
Issued: 2020-07-09
Expires: 2025-11-13
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-H8ZZKKAY
Issued: 2020-12-03
Expires: 2025-12-04
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-9BNY4I85
Issued: 2020-03-25
Expires: 2025-09-13
Loading CDMO intelligence...
Key facts about Cell and Gene Therapy Catapult
- Cell and Gene Therapy Catapult is headquartered in the United Kingdom.
- Cell and Gene Therapy Catapult was founded in 2011.
- Cell and Gene Therapy Catapult has 2,406 employees.
- Cell and Gene Therapy Catapult's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Cell and Gene Therapy Catapult
Directory pages this company appears in, each with the full list of matching manufacturers.